Position in ZYME
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$945,935
+$475,471 QoQ
Shares Held
37,777
+111.4% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HSBC HOLDINGS PLC holds $961,918,485 across 122 Biotechnology names. ZYME ranks #38 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
655,443 | $292,681,510 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
323,338 | $249,823,869 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,544,018 | $74,066,541 | |
| 4 | INCY |
Incyte Corp
|
582,368 | $54,812,474 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
89,619 | $29,652,235 | |
| 6 | MRNA |
Moderna, Inc.
|
490,088 | $24,896,468 | |
| 7 | INSM |
INSMED Inc
|
116,456 | $19,042,883 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
227,059 | $15,469,528 |
All Filings in ZYME
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $945,935 | 37,777 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $470,464 | 17,868 | Shares | Defined | 2026-03-20 | |
| 2025-09-30 | $642,208 | 37,600 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $458,037 | 36,497 | Shares | Defined | 2025-08-13 | |
| 2023-12-31 | $122,072 | 11,749 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $74,488 | 11,749 | Shares | Defined | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||